Personalized medicine: Time for one-person trials

Nicholas J. Schork(Translational Genomics Research Institute)

Nature

April 25, 2015

10.1038/520609a

Cited by 1,206Open Access

Abstract

Related Papers

<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker et al.|New England Journal of Medicine|2008|3.6k

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

Brian Druker, Charles L. Sawyers, Hagop M. Kantarjian et al.|New England Journal of Medicine|2001|2.7k

Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes

Rui Chen, George I. Mias, Jennifer Li‐Pook‐Than et al.|Cell|2012|1.3k

Using N-of-1 Trials to Improve Patient Management and Save Costs

Paul Scuffham, Jane Nikles, Geoffrey Mitchell et al.|Journal of General Internal Medicine|2010|90

Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule

Charles W. Drescher, Chirag Shah, Jason D. Thorpe et al.|Journal of Clinical Oncology|2012|75